SUMMARY It has been shown that the maximal rate of left ventricular (LV) relaxation is impaired in patients with coronary artery disease (CAD) under basal conditions. To test the hypothesis that this impaired LV relaxation could be related to viable but metabolically abnormal myocardium, we studied the time course of isovolumic LV pressure fall in 21 patients with CAD and in 13 control subjects under basal conditions. This study was repeated after intracoronary injection of the calcium antagonist nifedipine (N) in 11 patients with CAD and in eight controls. Our data showed that isovolumic pressure fall was biexponential in 20 of 21 CAD patients and in six of 13 controls. Moreover, the time constant of isovolumic pressure fall during the first 40 msec after peak (negative) dP/dt (TJ) was significantly greater in CAD patients than in controls (62 ± 3 vs 44 ± 1 msec, p < 0.002); the time constant of pressure fall during the 40-80 msec after peak (negative) dP/dt (T2) was similar in both groups (42 ± 2 vs 39 ± 2 msec, NS). Thirty seconds after injection of nifedipine, T1 and T2 were significantly prolonged in patients with CAD (14 msec and 16 msec, respectively,p < 0.005) and in controls 12 msec and 14 msec, respectively, p < 0.05), and a negative inotropic effect was observed in both groups (peak (positive) dP/dt -16% in controls and -23% in CAD patients, p < 0.01).
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At rest, impairment of isovolumic relaxation in CAD patients is mainly limited to the first 40 msec after peak (negative) dP/dt, suggesting a dyssynchronous wall motion. This impairment of LV relaxation is better identified by T1 than by peak (negative) dP/dt in individual patients, and cannot be improved by administration of a calcium antagonist.
CARDIAC MUSCLE relaxation -the return to its initial length and tension -is a complex, energydependent process.' Animal data show that relaxation is impaired by various mechanical or inotropic interventions and during ischemia in isolated cardiac muscle, [1] [2] [3] controlled heart preparations4"12 and conscious animals.'3 1 ' In patients with coronary artery disease (CAD), the rate of left ventricular relaxation estimated from the peak (negative) dP/dt or from the time course of isovolumic pressure fall is impaired during pacing-induced angina."- 17 Papapietro et al. '8 reported that the rate of left ventricular relaxation is also impaired under basal resting conditions in CAD patients. This observation can be related to the presence of either scar tissue within the ventricular wall or chronically ischemic but viable myocardial tissue. Papapietro et al. ' 8 favor the latter hypothesis and suggest that myocardial ischemia impairs left ventricular relaxation in patients with CAD both at rest and during angina. This hypothesis is based on the observation that ischemia markedly prolongs ventricular relaxation;7' 8, 10-12 experimental data on isolated hearts suggest that depressant effects of ischemia on relaxation could be related to depletion of the high-energy phosphates stores needed to sequester calcium.8 11 The aim of the present study was to confirm this hypothesis by a careful analysis of the isovolumic left ventricular pressure fall in the basal conditions in normal subjects and in patients with CAD. In addition, because alterations in relaxation are in some way related to the myoplasmic calcium concentrations, '9 we also studied the effects of Ca++ antagonists on left ventricular relaxation.
Materials and Methods Patient Selection
Thirty-four consecutive patients (mean age 47.4 years, range 26-61 years) were included in this study. All patients were in sinus rhythm, and patients with hypertension or valvular disease were excluded. All patients had typical or atypical angina pectoris, and the hemodynamic study was performed for diagnostic purposes. Significant CAD, defined as stenosis of 75% or greater in at least one coronary vessel, was shown in 21 patients, all of whom had typical angina. Thirteen patients with completely normal coronary arteries and left ventriculography served as controls. Clinical and angiographic data are presented in table 1 . In the control group, 10 subjects had entirely normal left ventricular function; subjects 3, 4 and 5 of the control group had left ventricular end-diastolic pressures (LVEDP) of 18, 20 and 29 mm Hg, respectively, despite normal ejection fraction, wall motion and myocardial mass. Consequently, although no precise myocardial, pericardial, vascular or valvular disease could be found, these three subjects will not be referred to as normal. All cardioactive drugs were discontinued at least 24 hours before the procedure and In all patients, hemodynamic data (heart rate, systolic and diastolic aortic pressures, left ventricular systolic pressure, LVEDP and peak (positive) and (negative) dP/dt were first measured under basal conditions (control I). The Bourassa catheter was then introduced in the left main coronary artery and a second set of control data (control II) was obtained after the position of the catheter was checked by injection of 2 ml of contrast material. Hemodynamic variables were recorded simultaneously during two to three respiratory cycles on a multichannel recording system (Honeywell 1858) at a paper speed of 200 mm/sec. Then, in control subjects 1-8 and in CAD patients 1-11 (table 1), a 0.1-mg bolus of nifedipine was injected into the left main coronary artery, and data were recorded 30 seconds, 1, 2, 3 and 5 minutes after injection.
Measurements and Computations
In each recording, the cardiac cycle with the highest LVEDP (measured at the peak of the R wave) was selected for analysis. This procedure ensured that the beat was selected in expiratory phase and prevented artifactual changes in the time course of left ventricular pressure fall due to variations in intrathoracic pressures. LVEDP values obtained in this fashion are higher than those obtained by averaging LVEDP over the entire respiratory cycle.
The time course of fall of left ventricular pressure was used as an index of left ventricular relaxation.6' 9, 13 Left ventricular pressure was digitized every 5 msec, and pressure vs time data for 80 msec after peak (negative) dP/dt were first fitted into a single exponential relationship by the method of least squares ( fig. IA) . The time constant "T" of this relationship was used as an index of left ventricular relaxation.6' 9, 13 However, despite high correlation coefficients (r = 0.986-0.999, p < 0.001), this procedure did not perfectly reflect the decrease in pressure in most patients. In six of the 13 control subjects and in 20 of the 21 patients with CAD, visual inspection of the data revealed that left ventricular pressure fall during the first 40 msec after peak (negative) dP/dt (T,) was slower than that during 40-80 msec after peak negative dP/dt (T,) ( fig. 1B ).
Statistical analysis confirmed this observation in patients with CAD. When T, values for left ventricular pressure fall were fitted to a single exponential, the time constant of this exponential was significantly greater (62.0 ± 2.7 msec vs 42.2 ± 1.8 msec, p < 0.001; n = 21) than the time constant obtained by fitting the T, values for left ventricular pressure fall. If the pressure fall had been monoexponential, these two time constants should have been identical or, at least, not statistically different. In addition, the fact that a best fit of the real pressure data was obtained by a biexponential rather than by a monoexponential relationship demonstrated by the smallest sum of squares of the deviation from the fitted relationship (0-80 msec) obtained with a biexponential fit (p < 0.002). In the control group, the first 40 msec of the pressure fall (TJ) also tended to be slower than during the next 40 msec (T,) (43.5 ± 1.4 msec vs 39.0 ± 2.0 msec), but this difference was not statistically significant.
Thus, in 46% of control patients and in 95% of patients with CAD, the isovolumic pressure fall was biexponential. Accordingly, we decided to present in all patients T1 and T, values as well ( fig. 1B ).
Statistical Analysis
In each group, the data collected after administration of nifedipine were compared with the two control values using a repeated-measure analysis of variance. 20 Comparisons between groups were performed using a two-tailed Mann-Whitney test. T ms eight patients were similar to those of the control subjects. In addition, peak (negative) dP/dt (-2492 ± 240 mm Hg/sec) and T values ( fig. 2, left) were not significantly altered. However, even in these CAD patients with normal left ventricular function, T1 was significantly prolonged (55.0 ± 2.3 msec vs 43.5 ± 1.4 msec, p < 0.02). Further, T2 values in these CAD patients were similar to those in the control subjects ( fig. 2, right) .
Effects of Intracoronary Nifedipine on Control Subjects
The data on heart rate, left ventricular pressures and indexes of left ventricular relaxation for all patients included in the nifedipine study are summarized in table 2.
Thirty seconds after administration of nifedipine to control subjects 1-8, small but significant increases in heart rate (7 beats/min, p < 0.05) and LVEDP (3.8 mm Hg, p < 0.01) were noted. Peak (positive) dP/dt decreased by 16% (p < 0.01) and T, T1 and T2 values were all prolonged by approximately 14 msec (p < 0.05). There were only minor, nonsignificant changes in peak (negative) dP/dt (-9%). After 2 minutes, all variables returned to the control values. As in control subjects, 30 seconds after intracoronary administration of nifedipine, significant increases in heart rate (9 beats/min, p < 0.05) and LVEDP (5.6 mm Hg, p < 0.005) occurred. Peak (12 mm Hg, p < 0.05) and peak (negative) dP/dt (-26%, p < 0.05) were noted. Increased LVEDP, heart rate changes and depression of peak (positive) dP/dt were still present 1 minute after injection, but after 2 minutes, no value differed significantly from control.
Effects of Nifedipine in Control and CAD Groups
After nifedipine, T, values remained significantly higher in the CAD group than in the control group (77.8 ± 4.9 vs 58.2 ± 4.9 msec, p < 0.02). Moreover, the hemodynamic data (table 2) suggested that patients with CAD could be more sensitive to nifedipine. There were significant decreases in peak (negative) dP/dt and left ventricular systolic pressure after administration of nifedipine in the CAD group, but these variables were not significantly altered in the control group. In addition, changes in peak (positive) dP/dt, heart rate and T, T, and T2 values tended to be more accentuated and to last longer in CAD patients.
To test the hypothesis that nifedipine could modify left ventricular relaxation more markedly in CAD patients than in control subjects, we compared the increase in T, values produced by nifedipine in both groups and found similar increases ( fig. 3A) .
However, increases in T, after administration of Nifedipine were significantly lower in patients with LVEDP less than or equal to 15 mm Hg under basal conditions (five control subjects and five CAD patients) than in patients with high LVEDP (six CAD patients and three control subjects) ( fig. 3B ).
Discussion
Our study showed that indexes of left ventricular relaxation are depressed under basal conditions in CAD patients. Further, our data indicate that nifedipine, which slows the transmembrane influx of calcium into myocardial cells,22 markedly prolonged rather than improved this impaired relaxation.
Mechanisms of Impairment in Left Ventricular Relaxation in CAD Patients
Two indexes of left ventricular relaxation were used in this study. The clinical usefulness of peak (negative) dP/dt has been established.5' 15, 17 Our observation that the peak (negative) dP/dt is lower at rest in CAD patients than in control subjects supports recent data by Papapietro et al. 18 However, the wide overlap between groups ( fig. 4 ) and the fact that peak (negative) dP/dt was no longer significantly different between CAD and control groups after administration of nifedipine suggests that this index is not sensitive enough to discriminate normal from abnormal relaxation in individual patients. This finding is probably ex- plained by the sensitivity of peak (negative) dP/dt to various mechanical events.5 23 We used the time course of left ventricular pressure fall during isovolumic relaxation6' 913, 17 as a second index. Weiss et al.6 and Frederiksen et al.9 showed that, in dogs, isovolumic pressure fall after peak (negative) dP/dt was monoexponential for at least 100 msec and could therefore be characterized by the time constant T of this exponential. Their studies showed that T was unaffected by changes in the left ventricular systolic pressure or LVEDP, stroke volume or velocity of shortening, but decreased with positive inotropic interventions.6' 9 Accordingly, we determined T values by fitting the left ventricular pressure decay during 80 msec after peak (negative) dP/dt to a single exponential ( fig. 1) fig. 2,  left) . Nevertheless, the data revealed that in 20 of 21 CAD patients and in six of 13 control subjects, the left ventricular pressure fall was biexponential rather than monoexponential ( fig. 1) 28 Similarly, drugs that reduce the pumping ability of the sarcoplasmic reticulum, such as Ryanodine, will slow relaxation,29 and in Ryanodine-treated myocardium, any increase in calcium will further impair relaxation,30 whereas any decrease in calcium will improve relaxation. 29 We therefore hypothesized that relaxation was impaired in CAD patients because of an increase in myoplasmic calcium resulting either from an increase in calcium release or from a decrease in pumping ability of the sarcoplasmic reticulum. Consequently, we expected that nifedipine, a calcium antagonist, would improve this impaired relaxation, unless sarcoplasmic reticulum were completely unable to pump calcium. (Complete block of the sarcoplasmic reticulum, though proved in severe ischemia,11 is unlikely under basal condition.) However, nifedipine significantly prolonged relaxation in both groups.
We offer two explanations for this impaired ventricular relaxation. First, nifedipine may also block reuptake of calcium by the sarcoplasmic reticulum. Second, other factors, besides calcium and sarcoplasmic reticulum, may regulate the relaxation rate. These factors could be impaired in CAD patients under basal conditions, and could be further impaired by nifedipine. In favor of this second hypothesis are the observations that changes in relaxation rate produced by several interventions cannot always be explained by a simple relationship between calcium levels and a constant pumping rate. This is observed during changes in the frequency of stimulation, or after the administration of catecholamines, calcium or caffeine."' 4 9 "9 Such maneuvers are supposed to increase calcium but, as opposed to postextrasystolic potentiation,28 they markedly increase the relaxation rate as well. It is therefore likely that the pumping rate of the sarcoplasmic reticulum is regulated by biochemical feedbacks dependent on the degree of activation of the cell.' In this perspective, the slow relax- ation rate in CAD patients could be explained by a decrease in the activation of the myofibrils. Such decrease in activation in the myocardium of the CAD patients could be related under basal conditions to the depletion in myocardial catecholamines recently described in chronic ischemic heart disease.31 Nifedipine, which further decreases activation by decreasing calcium influx, should further prolong relaxation instead of improving it.
In conclusion, our study shows that at rest, impairment of isovolumic relaxation in CAD patients is not uniform but mainly limited to the first 40 msec after peak (negative) dP/dt. This impairment of left ventricular relaxation is better identified by T1 than peak (negative) dP/dt in individual patients. This inhomogeneity of ventricular relaxation suggests the presence of abnormal myocardial cells in CAD patients, even under basal conditions. Further pharmacologic and physiopathologic studies are required to elucidate the behavior of this muscle.
